MiR-149 has been shown to exert an oncogenic role in T-cell acute lymphoblastic leukemia by downregulating the expression of Jun-B in these cells, leading to enhanced cellular proliferation and decreased apoptosis [31]. The gene discussed is JUNB; the disease is T-cell acute lymphoblastic leukemia.